Some persons at high risk of lymphoproliferative diseases = Certaines personnes à haut risque de maladies lymphoproliférativesMILLER, R. W.Progress in cancer research and therapy. 1984, Vol 27, pp 201-205, issn 0145-3726Article

American Society of Hematology twenty-fifth annual meeting, San Francisco, California, December 3-6, 1983. Abstracts = American Society of Hematology. 25ème réunion annuelle, San Francisco, Californie, 3-6 Décembre 1983. RésumésBlood. 1983, Vol 62, Num 5, issn 0006-4971, 311 p.Conference Proceedings

The 'Sandwich Sign' of Mesenteric LymphomaKURUPPU, Dinuka; VENKATANARASIMHA, Nanda; DUBBINS, Paul et al.British journal of haematology. 2010, Vol 149, Num 4, issn 0007-1048, p. 463Article

LymphomaHARRIS, Michael Frank; KNECHTLI, Christopher.BMJ (Overseas and retired doctors ed.). 2014, Vol 348, Num 7964, pp 32-33, issn 1759-2151, 2 p.Article

Lymphomes hodgkiniensBRICE, Pauline.Hématologie (Montrouge). 2007, Vol 13, pp 28-30, issn 1264-7527, 3 p., NS1Conference Paper

Mise en place d'un registre des hémopathies malignes en Côte d'Or. Premiers résultats = A registry of malignant hematological diseases in the department of Côte d'Or (France)CARLI, P. M; MILAN, C; LORENZINI, J. L et al.Nouvelle revue française d'hématologie. 1983, Vol 25, Num 5, pp 329-335, issn 0029-4810Article

Comment donner le diagnostic d'hémopathie maligne? = How to gives the diagnosis of a malignant hemopathyALBY, N.Actualités hématologiques. 1983, Vol 17, pp 137-140, issn 0567-8757Article

Hematological malignanciesMELLSTEDT, Hakan; BARISTA, Ibrahim; DIMOPOULOS, Meletios et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, x135-x159, SUP10Conference Paper

Pathogenesis of leukemias and lymphomas: environmental influences. Workshop held at the National Institutes of Health, in May 1982 = Pathogenèse des leucémies et lymphomes: influence de l'environnement. Réunion de travail tenue au National Institute of Health, en mai 1982MAGRATH, I. T; O'CONOR, G. T; BRACHA RAMOT, Ed et al.Progress in cancer research and therapy. 1984, Vol 27, issn 0145-3726, XXVIII-399 pConference Proceedings

ESCAPE OF SMALL NUMBERS OF ALLOGENEIC LYMPHOMA CELLS FROM IMMUNE SURVEILLANCEBONMASSAR E; MENCONI E; GOLDIN A et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 53; NO 2; PP. 475-479; BIBL. 15REF.Article

HORMONE-DEPENDENT STEM-CELL RAT LEUKEMIA EVOKED BY A SERIES OF FEEDINGS OF 7,12-DIMETHYLBENZ (A) ANTHRACENE = LEUCEMIE DU RAT A CELLULES SOUCHES HORMONO-DEPENDANTE PROVOQUEE PAR UNE SERIE D'ADMINISTRATIONS DE DIMETHYL-7,12-BENZ(A)ANTHRACENEHUGGINS CB; YOSHIDA H; BIRD CC et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 52; NO 4; PP. 1301-1305; BIBL. 12REF.Article

NEOPLASTISCHE BLUTERKRANKUNGEN IM ALTER = HEMOPATHIES NEOPLASIQUES DE LA VIEILLESSEBRUECHER H.1972; Z. ALTERNSFORSCH.; DTSCH.; DA. 1972; VOL. 26; NO 1-2; PP. 75-87; BIBL. 3REF.Serial Issue

LEUKAEMIA AND ALLIED DISORDERS. 1. CONCEPTS, DEFINITIONS AND CLASSIFICATIONS = LEUCEMIE ET DESORDRES APPARENTES. 1. CONCEPTS: DEFINITIONS ET CLASSIFICATIONS1972; MED. J. AUSTRAL.; AUSTRAL.; DA. 1972; VOL. 59; NO 26; PP. 1359-1365; BIBL. 1P.Serial Issue

Histiocytic lymphoma of the stomachDEODHAR, S. D; JAMMIHAL, H. J; KANE, S. V et al.Journal of Postgraduate Medicine (Bombay). 1983, Vol 29, Num 2, pp 117-119, issn 0022-3859Article

The clinical use of antibodies in haematological malignanciesLOPEZ-GUILLERMO, A; MERCADAL, S.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix51-ix57, SUP9Conference Paper

In vitro determination of tumour chemosensitivity in haematological malignanciesBIRD, M. C; BOSANQUET, A. G; GILBY, E. D et al.Hematological oncology. 1985, Vol 3, Num 1, pp 1-9, issn 0278-0232Article

Invasion of the sternum by lymphoma-role of CTSTARK, P.Der Radiologe (Berlin. Print). 1984, Vol 24, Num 3, pp 130-132, issn 0033-832XArticle

Lactate dehydrogenase isoenzyme activity in malignant haematological diseasesPAULE, B; FRANCOUAL, J; LINDENBAUM, A et al.Biomedicine & pharmacotherapy. 1984, Vol 38, Num 1, pp 62-65, issn 0753-3322Article

Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancySCHUSTER, D. P; MARION, J. M.The American journal of medicine. 1983, Vol 75, pp 402-408, issn 0002-9343Article

Antiangiogenic therapy in hematologic malignancies : HaematologyMOEHLER, T. M; HILLENGASS, J; GOLDSCHMIDT, H et al.Current pharmaceutical design. 2004, Vol 10, Num 11, pp 1221-1234, issn 1381-6128, 14 p.Article

The use of monoclonal antibodies in clinical haematology. The art of limitationHOKLAND, P.Scandinavian journal of haematology. 1984, Vol 33, Num 1, pp 5-8, issn 0036-553XArticle

Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies = Polarisation de fluorescence, un paramètre des lipides plasmatiques chez les malades atteints de néoplasies hématologiquesSPIEGEL, R. J; SCHAEFER, E. J; MAGRATH, I. T et al.Leukemia research. 1983, Vol 7, Num 5, pp 647-654, issn 0145-2126Article

Significance of chromosome change to hematopoietic neoplasms = Signification des modifications chromosomiques des hémopathies malignesCHAGANTI, R. S. K.Blood. 1983, Vol 62, Num 3, pp 515-524, issn 0006-4971Article

Myeloid and lymphoid neoplasm with FGFR1 abnormalityKEANE, Colm; MILLS, Tony; HENDEN, Andrea et al.British journal of haematology. 2009, Vol 145, Num 4, issn 0007-1048, p. 440Article

Cytogénétique et hémopathies malignes (à l'exception des lymphomes) = Cytogenetics and malignant hemopathyFENAUX, P; LAI, J. L; KERCKAERT, J. P et al.Lille médical (1987). 1989, Vol 29, Num 1, pp 27-31, 5 p.Article